Neonatal Klebsiella pneumonia sepsis and imipenem/cilastatin

Indian Journal of Pediatrics

Volumn 65, Issue 1, 1998, Pages 121-129

  Oral, Resmiye ^c   Akisü, Mete ^a   Kültürsay, Nilgün ^b   Vardar, Fadil ^a   Tansuĝ, Nermin ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Division of Neonatology   (Turkey)

^c Department of Pediatrics ^*

Author keywords

Imipenem; Klebsiella pneumonia; Newborn; Sepsis

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CEFOXITIN; CILASTATIN PLUS IMIPENEM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NEWBORN; NEWBORN SEPSIS; SEIZURE; SUPERINFECTION; THROMBOCYTOSIS; THROMBOPHLEBITIS;

EID: 0031968434     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849703     Document Type: Article

References (25)

1. Gotoff SP. Infections of the neonatal infant. In : Beharman RE, Kliegman RM, Arvin AM. eds. Textbook of Pediatrics. Philadelphia : W.B. Saunders Colmpany, 1996 : 514-450.
2. Toltzis P, Blumer JL, Antibiotic resistant gram-negative bacteria in the critical care setting. Pediatr Clin North Am 1995; 42 : 687-702.
3. Arvas A, Perk Y, Gür E,'Ilter Ö. 1989-1992 yillari arasinda Yenidogan Ünitesinde izlenen bebeklerde infeksiyon dagilimi. Proceedings of XXX. Turkish Pediatric and II. National neonatology Congress, June 14-18th, 1993, Istanbul : pp 37-9.
4. Oygür N. Yenidogan Ünitesinde Nozokomiyal infeksiyonlarin yillara göre dagilimi. Proceedings of XXX. Turkish Pediatrics and II. National Neonatolgy Congress, June 14-18th, 1993, Istanbul : pp 33-34.
5. Satar M, Atici A, Yilmaz M. Yenidogan Ünitesinde Hastane Infeksiyonlari. Proceedings of XXX. Turkish Pediatrics and II. National Neonatology Congress, June 14-18th, 1993, Istanbul : pp 40.42.
6. Ertogan F, Arsan S. Nozokomiyal infeksiyonlar (1988-1992). Proceedings of XXX. Turkish Pediatrics and II. National Neonatology Congress, June 14-18th, 1993 Istanbul : pp 35-36.
7. Kültürsay N, Kütükcüler N, Tansug N, Kutlu O, Etiology, treatment and prognosis of early-onset and nosocomial septicemia in neonatal intensive care unit. Annals Med Scien 1995; 4 : 1-7.
8. Kültürsay N, Tansug N, Kütükçüler N, Tokbas A, Kutlu O. Ceftazidime treatment in severe neonatal infections. Annals Med Scien 1995; 4 : 8-12.
9. Freij BJ, McCracken GH, Olsen KD, Threlkeld N. Pharmacokinetics of imipenem-cilastatin in neonates. Antimicrob Ag Chemother 1985; 27 : 431-435.
10. Buckley MM, Brogden RN, Barradell LB, Goa KL. Imipenem-cilastatin. Drugs 1992; 44 : 408-444.
11. Lorens XS, Mccracken GH. Clinical Pharmacology of antibacterial agents. In : Remington J.S, Keelin J.O. eds. Infectious Disease of the fetus and newborn infants. Philadelphia : W.B. Saunders Company, 1995 : 1310-1331.
12. Nalin DR, Hart CB, Shih WJ, Aziz MA. Imipenem-cilastacin for pediatric infections in hospitalized patients. Scand J Infect Dis 1987; 19 (Suppl) 52 : 56-64.
13. Star SE. Antibacterial therapy of bacterial sepsis in the newborn. J Pediatr 1985; 106 : 1043-1043.
14. Geddes A, Roylance PJ. Clinical experience with imipenem cilastatin : a 5 year overview. Curr Op Infect Dis 1991; 4 (suppl 1) : 53-59.
15. Alpert G, Dagan R, Connor E et al. Imipenem-cilstatin for the treatment of infections in hospitalised children. Am J Dis Child 1985; 139 : 1153-1156.
16. Nalin DR, Jacobson CA. Imipenemcilastatin therapy for serious infection in neonates and infants. Scand J Infect Dis 1987; 19 (suppl 52) : 2-11.
17. Ahonkai VI, Cyhan GM, Wilson SE, Brown KR. Imipenem-cilastatin in pediatric patients : an overview of safety and efficacy in studies conducted in the United States. Pediat Infect Dis J 1989; 8 : 740-744.
18. Collins MA, Tyoypin M. Collaborative Imipenem-cilastatin study group. Clinical evaluation of Imipenem-cilastatin as a single agent therapy for sepsis neonatorum. 27th Intersci Conf Antimicrob Chemother Agents 1987; Abstract, p. 525.
19. Reisch O, Ashkenazi S, Naor N. An outbreak of multiresistant Klebsiella in a neonatal intensive care unit. J Hosp Infect 1993; 25 : 287-289.
20. Somer A, Salman N, Palanduz A, Guler N, Yalcin I, Ones U. Cocuklarda ciddi infeksiyonlarin tedavisinde Imipenem-cilastatin kullanimi. Proceedings of 10th Turkiye Antibiotics and Chemotherapy Congresss, June 6-9th 1995, Antalya, p. 167.
21. Mutlu G, Candan M, Pektas O, Bulut M. Cerrahi problemi olan yenidoganlarin ciddi infeksiyonlarinda Imipenemcilastatin kullanimi. Proceedings of 10th Turkiye Antibiotics and Chemotherapy Congress, June 6-9th 1995, Antalya, p 151.
22. Favero AD. Clinically important aspects of carbapenem safety. Cur Op Infect Dis 1994; 7 (Suppl 1) : 38-42.
23. Asensi F, Otero MC, Perez-Tamarit et al. Risk/benefit in the treatment of children with Imipenem-cilastatin for meningitis caused by penicillin resistant pneumococcub. J Chemother 1993; 5 : 133-134.
24. Ucsel R, Coban A, Karabiyik N, Metin F, Yucer G, Can G. Yenidogan infeksiyonlarinda Imipenem-cilastatin kullanimi ile ilgili deneyimlerimiz. 1st Tip Fak Mec 1995; 58 : 37-40.
25. Gruber WC, Rench MA, Garcia-Pratz JA, Edwards MS, Baker CJ. Single-dose pharmacokinetics of Imipenem-cilastatin in neonates. Antimier Agent Chemother 1985; 27 : 511-514.